Evidence map›Paper›PMID 16416422›Full record

ArticleGenesis (New York, N.Y. : 2000)2006

Conditional gene recombination by adenovirus-driven Cre in the mouse uterus.

Haibin Wang, Huirong Xie, Hao Zhang, Sanjoy K Das, Sudhansu K Dey

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Haibin WangDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2678, USA.
Huirong Xie
Hao Zhang
Sanjoy K Das
Sudhansu K Dey
Vanderbilt University Medical Center · USZero to Three · US

Funding

THE ROLE OF ENDOCANNABINOIDS AND THEIR RECEPTORS IN COLORECTAL CANCERP01CA077839 · NCI · VANDERBILT UNIVERSITY · PI DUBOIS, RAYMOND N. · 1999 to 2016
$17.8M
UTERINE VASCULAR CHANGES &ANGIOGENESIS DURING IMPLANTATIONU54HD033994 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI TERRANOVA, PAUL FRANK · 2001 to 2005
$5.6M
Endocannabinoid Signaling During Early PregnancyR37DA006668 · NIDA · VANDERBILT UNIVERSITY · PI DEY, SUDHANSU K · 2003 to 2012
$3.8M
ENVIRONMENTAL TOXINS AND UTERINE GENE EXPRESSIONR01ES007814 · NIEHS · VANDERBILT UNIVERSITY · PI DAS, SANJOY K. · 1997 to 2012
$3.2M
ASPECTS OF BLASTOCYST IMPLANTATIONR37HD012304 · NICHD · VANDERBILT UNIVERSITY · PI DEY, SUDHANSU K · 1999 to 2010
$2.9M
MARIJUANA EFFECTS ON EARLY PREGNANCYR01DA006668 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DEY, SUDHANSU K · 1990 to 2019
$2.1M
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATIONR01HD037830 · NICHD · VANDERBILT UNIVERSITY · PI DAS, SANJOY KUMAR · 2001 to 2005
$1.2M
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENTP30HD033994 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI TERRANOVA, PAUL · 1996 to 2000
$445k
ROLE OF HISTAMINE IN EARLY PREGNANCYR01HD012304 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DEY, SUDHANSU K · 1985 to 1998
–
NCI NIH HHS CA77839NCI NIH HHS P01 CA077839NICHD NIH HHS HD12304NICHD NIH HHS HD33994NICHD NIH HHS HD37830NICHD NIH HHS P30 HD033994NICHD NIH HHS R01 HD037830NICHD NIH HHS R37 HD012304NICHD NIH HHS U54 HD033994NIDA NIH HHS DA06668NIDA NIH HHS R01 DA006668NIDA NIH HHS R37 DA006668NIEHS NIH HHS ES07814NIEHS NIH HHS R01 ES007814
6 · The paper itself

Abstract

Cre-mediated conditional gene targeting has been shown to be successful in many cell and tissue types. However, gene recombination in the uterus with heterogeneous cell types by Cre activation is not yet well established. Using recombinant adenoviruses expressing a functional Cre (ADV-Cre) and ROSA26 reporter mice, we show here that ADV-Cre infused intraluminally in a small volume (10 microl) conditionally excises the loxP site, resulting in lacZ expression in uterine luminal epithelial cells without significantly affecting pregnancy. In contrast, a similar intraluminal infusion of ADV-Cre in a larger volume (50 microl) damages the normal architecture and integrity of the luminal epithelium, inducing gene recombination in the underneath stromal cells, with disruption of pregnancy. Further, decidualizing stromal cells at the implantation sites can be targeted by ADV-Cre after intravenous administration on days 5-6. This route of administration also elicits Cre activity in other tissues, including the liver, spleen, ovary, and, more remarkably, in the adrenal cortex. These findings demonstrate the feasibility of achieving conditional expression or deletion of specific genes in uterine cells at desired times and physiological states.

Indexed as

Genetic VectorsAdenoviridaeAnimalsDeciduaDose-Response Relationship, DrugEmbryo ImplantationFemaleGenes, ReporterIntegrasesMiceMice, TransgenicRecombination, GeneticUterusCre recombinaseIntegrases

Identifiers

PMID16416422
PMCPMC4267753
OpenAlexW2066646464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.